Are blood pressure and diabetes additive or synergistic risk factors Outcome in 8494 subjects randomly recruited from 10 populations

Hypertension Research

Volumn 34, Issue 6, 2011, Pages 714-721

  Sehestedt, Thomas ^a   Hansen, Tine W ^b   Li, Yan ^c   Richart, Tom ^d,e   Boggia, Jose ^f   Kikuya, Masahiro ^g   Thijs, Lutgarde ^d   Stolarz Skrzypek, Katarzyna ^h   Casiglia, Edoardo ⁱ   Tikhonoff, Valérie ⁱ   Malyutina, Sofia ^j   Nikitin, Yuri ^j   Björklund Bodegrd, Kristina ^k   Kuznetsova, Tatiana ^d   Ohkubo, Takayoshi ^g   Lind, Lars ^k   Torp Pedersen, Christian ^a   Jeppesen, Jørgen ^a   Ibsen, Hans ^a   Imai, Yutaka ^g   Wang, Jiguang ^c   Sandoya, Edgardo ^l   Kawecka Jaszcz, Kalina ^h   Staessen, Jan A ^d,e   more..

^a Mental Health Services CPH   (Denmark)

^b Rigshospitalet   (Denmark)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^g TOHOKU UNIVERSITY   (Japan)

^h JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^k UPPSALA UNIVERSITY   (Sweden)

^l Specialized Techniques Laboratory   (Uruguay)

more..

Author keywords

ambulatory blood pressure; cardiovascular risk factors; diabetes mellitus; epidemiology; population science

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79958138454     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2011.6     Document Type: Article

References (47)

1. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der Niepen P, O'Brien E, for the Office versus Ambulatory Pressure Study investigators. Prognostic value of ambulatory bloodpressure recordings in patients with treated hypertension. N Engl J Med 2003; 348: 2407-2415. (Pubitemid 36682819)
2. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. The Dublin Outcome Study. Hypertension 2005; 46: 156-161. (Pubitemid 40946507)
3. Hansen TW, Kikuya M, Thijs L, Björklund-Bodega°rd K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Jeppesen J, Ibsen H, Imai Y, Staessen JA, on behalf of the IDACO Investigators. Prognostic superiority of daytime ambulatory over conventionalblood pressure in four populations: a meta-analasis of 7030 individuals. J Hypertens 2007; 25: 1554-1564. (Pubitemid 47056557)
4. Stern N, Marcus Y. Hypertension in diabetes: the role of the vasculature. Curr Hypertens Rep 2004; 6: 90-97. (Pubitemid 39359548)
5. Cuspidi C, Meani S, Lonati L, Fusi V, Valerio C, Sala C, Magnaghi G, Maisaidi M, Zanchetti A. Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J Hypertens 2006; 24: 647-653.
6. Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among US adults with diabetes, 1988-1994. Am J Prev Med 2002; 22: 42-48. (Pubitemid 34037011)
7. Maahs DM, Kinney GL, Wadwa P, Snell-Bergeon JK, Dabelea D, Hokanson J, Ehrlich J, Garg S, Eckel RH, Rewers MJ. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care 2005; 28: 301-306. (Pubitemid 40170930)
8. Eguchi K, Ishikawa J, Hoshide S, Pickering TG, Schwartz JE, Shimada K, Kario K. Nighttime blood pressure variability is a strong predictor for cardiovascular events in patients with Type 2 diabetes. Am J Hypertens 2009; 22: 46-51.
9. Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Furukawa Y, Kamide K, Kawanishi K, Okayama A, Yoshimasa Y. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study. Hypertens Res 2010; 33: 1238-1243.
10. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Br Med J 1998; 317: 703-713.
11. Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic hypertension in Europe trial investigators. N Engl J Med 1999; 340: 677-684. (Pubitemid 29110751)
12. Thijs L, Hansen TW, Kikuya M, Björklund-Bodegard K, Li Y, Dolan E, Tikhonoff V, Sleidlerová J, Kuznetsova T, Stolarz K, Bianchi M, Richart T, Casiglia E, Malyutina S, Filipovský J, Kawecka-Jaszcz K, Nikitin Y, Ohkubo T, Sandoya E, Wang JG, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA. The International Database of Ambulatory blood pressure in relation to Cardiovascular Outcome (IDACO): protocol and research perspectives. Blood Press Monit 2007; 12: 255-262. (Pubitemid 47356413)
13. Hansen TW, Jeppesen J, Rasmussen F, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and mortality: a population-based study. Hypertension 2005; 45: 499-504. (Pubitemid 40411250)
14. Staessen JA, Bieniaszewski L, O'Brien ET, Imai Y, Fagard R. An epidemiological approach to ambulatory blood pressure monitoring : the Belgian population study. Blood Press Monit 1996; 1: 13-26. (Pubitemid 126441345)
15. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20: 2183-2189. (Pubitemid 35388236)
16. Schettini C, Bianchi M, Nieto F, Sandoya E, Senra H, Hypertension Working Group. Ambulatory blood pressure. Normality and comparison with other measurements. Hypertension 1999; 34(Part 2): 818-825. (Pubitemid 29501306)
17. Li Y, Wang JG, Gao HF, Nawrot T, Wang GL, Qian YS, Staessen JA, Zhu DL. Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Press Monit 2005; 10: 125-134. (Pubitemid 40863084)
18. Ingelsson E, Björklund K, Lind L,Ä rnlöv J, Sundström J. Diurnal blood pressure pattern and risk of congestive heart failure. JAMA 2006; 295: 2859-2866. (Pubitemid 43974183)
19. Kuznetsova T, Staessen JA, Kawecka-Jaszcz K, Babeanu S, Casiglia E, Filipovsk J, Nachev C, Nikitin Y, Pelesk J, O'Brien E, on behalf of the EPOGH Investigators. Quality control of the blood pressure phenotype in the European Project on Genes in Hypertension. Blood Press Monit 2002; 7: 215-224.
20. Kuznetsova T, Malyutina S, Pello E, Thijs L, Nikitin Y, Staessen JA. Ambulatory blood pressure of adults in Novosibirsk, Russia: interim report on a population study. Blood Press Monit 2000; 5: 291-296. (Pubitemid 32050460)
21. Imai Y, Nagai K, Sakuma M, Sakuma H, Nakatsuka H, Satoh H, Minami N, Munakata M, Hashimoto J, Yamagishi T, Watanabe N, Yabe T, Nishiyama A, Abe K. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension 1993; 22: 900-912. (Pubitemid 23358099)
22. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705 CP, Philips HP5332 and Nissei DS-175. Blood Press Monit 1996; 1: 55-62.
23. Fagard R, Brguljan J, Thijs L, Staessen J. Prediction of the actual awake and asleep blood pressures by variousmethods of 24h pressure analysis. J Hypertens 1996; 14: 557-563. (Pubitemid 26161109)
24. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker-Boudier HA, Zanchetti A, 2007 Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. (Pubitemid 46924065)
25. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19: 243-259.
26. Nawrot TS, Van Hecke E, Thijs L, Richart T, Kuznetsova T, Jin Y, Vangronsveld J, Roels HA, Staessen JA. Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmetally exposed population. Environ Health Perspect 2008; 116: 1620-1628.
27. Tikhonoff V, Staessen JA, Kuznetsova T, Thijs L, Hasenkamp S, Bäumer V, Stolarz K, Seidlerová J, Filipovský J, Nikitin Y, Peles?ka J, Kawecka-Jaszcz K, Casiglia E, Brand-Herrmann SM, Brand E, for the European Project on Genes in Hypertension (EPOGH) Investigators. SAH gene variants revisited in the European Project on Genes in Hypertension. J Hypertens 2008; 26: 244-250.
28. Easton DF, Peto J, Babiker AGAG. Floating absolute risk : an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med 1991; 10: 1025-1035.
29. Eguchi K, Pickering TG, Hoshide S, Ishikawa J, Ishikawa S, Schwartz JE, Shimada K, Kario K. Ambulatory blood pressure is a better marker than clinic blood pressure in predicting cardiovascular events in patients with/without Type 2 diabetes. Am J Hypertens 2008; 21: 443-450. (Pubitemid 351450870)
30. Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, Parving HH. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J Hypertens 2007; 25: 2479-2485. (Pubitemid 350060387)
31. Mannucci E, Lambertucci L, Monami M, Fedeli A, Chiasserini V, Marchionni N, Masotti G, Ungar A. Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study. Diabetes Metab Res Rev 2006; 22: 172-175. (Pubitemid 43805396)
32. Palmas W, Pickering TG, Teresi J, Schwartz JE, Moran A, Weinstock RS, Shea S. Ambulatory blood pressure monitoring and all-cause mortality in elderly people with diabetes mellitus. Hypertension 2009; 53: 120-127.
33. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: 434-444. (Pubitemid 23046633)
34. Asia Pacific Cohort Studies Collaboration. Coronary risk prediction for those with and without diabetes. Eur J Cardiovasc Prev Rehabil 2006; 13: 30-36.
35. Iso H, Imano H, Kitamura A, Sato S, Naito Y, Tanigawa T, Ohira T, Yamagishi K, Iida M, Shimamoto T. Type 2 diabetes and risk of non-embolic ischaemic stroke in Japanese men and women. Diabetologia 2004; 47: 2137-2144. (Pubitemid 40174686)
36. Adlerberth AM, Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care 1998; 21: 539-545. (Pubitemid 28172931)
37. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006; 49: 1761-1769. (Pubitemid 44025030)
38. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation 1979; 59: 8-13. (Pubitemid 9082394)
39. Gu Q, Burt VL, Paulose-Ram R, Yoon S, Gillum RF. High blood pressure and cardiovascular disease mortality risk among US adults: the third National Health and Nutrition Examination Survey mortality follow-up study. Ann Epidemiol 2008; 18: 302-309.
40. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J. The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke 2005; 36: 2538-2543.
41. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, on behalf of the SCORE project group. Estimates of 10-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. (Pubitemid 36712275)
42. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847. (Pubitemid 28213628)
43. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310-315. (Pubitemid 34106178)
44. Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-679. (Pubitemid 33135349)
45. Guzder RN, Gatling W, Mullee MA, Mehta RL, Byrne CD. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study. Diabet Med 2005; 22: 554-562. (Pubitemid 40593130)
46. Coleman RL, Stevens RJ, Retnakaran R, Holman RR. Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type. 2 diabetes. Diabetes Care 2007; 30: 1292-1293.
47. Cushman WC, Evans GW, Byington RP, Goff Jr DC, Grimm Jr RH, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585.